 Unum Therapeutics Inc NASDAQ:UMRX Equities researchers at Wedbush increased their Q3 2020 EPS estimates for Unum Therapeutics in a report issued on Wednesday, July 8th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of 0.03 per share for the quarter, up from their prior estimate of 0.04. Wedbush currently has ... 